Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: Support Care Cancer. 2022 Jan 28;30(5):4291–4301. doi: 10.1007/s00520-021-06755-z

Table 3.

Work-related problems and benefits reported by surveyed women with metastatic breast cancer

Overall
(n=133)
Stably working
(n=72)
No longer working
(n=61)
p-value
Encountered problems at work due to metastatic cancer or its treatment, (n, %) (n=129) (n= 68) (n=61)
 Being demoted or not being promoted 7 (5.4%) 6 (8.8%) 1 (1.6%) 0.07
 Being given less desirable work assignments 7 (5.4%) 4 (5.9%) 3 (4.9%) 0.81
 Being intimidated 12 (9.3%) 5 (7.4%) 7 (11.5%) 0.42
 Being laid off 5 (3.9%) 1 (1.5%) 5 (8.2%) 0.07
 Being suspended 1 (0.8%) 0 1 (1.6%) 0.29
 Denial of benefits/insurance 6 (4.7%) 3 (4.4%) 3 (4.9%) 0.89
 Denied reasonable accommodations 7 (5.4%) 3 (4.4%) 4 (6.6%) 0.59
 Encouraged to obtain pension 5 (3.9%) 1 (1.5%) 4 (6.6%) 0.14
 Harassment 5 (3.9%) 2 (2.9%) 3 (4.9%) 0.56
 Reduction in wages 11 (8.5%) 7 (10.3%) 4 (6.6%) 0.45
 Other 12 (9.3%) 5 (7.4%) 7 (11.5%) 0.42
Received work-related benefits, (n, %) (n=128) (n=67) (n=61)
 Compassionate allowance 10 (7.8%) 4 (6%) 6 (9.8%) 0.42
 Long term disability benefits 31 (24.2%) 13 (19.4%) 18 (29.5%) 0.18
 Short term disability benefits 47 (36.7%) 21 (31.3%) 26 (42.6%) 0.19
 Sick leave 68 (53%) 34 (50.8%) 34 (55.7%) 0.57
 Unpaid time off 33 (25.8%) 17 (25.4%) 16 (26.2%) 0.91
 Other 21 (16.4%) 13 (19.4%) 8 (13.1%) 0.34

Response category permitted more than one selection (e.g., “all that apply”). Thus, columns sum may exceed 100%.